http://www.ultragenyx.com
Ultragenyx Pharmaceutical Inc. Company Intro
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
Industry
Healthcare
Ultragenyx Pharmaceutical Inc. Headquaters
60 Leveroni Court
Novato,94949
United States
Ultragenyx Pharmaceutical Inc. Share price
27 Jan 2021 02:28 GMT
$147.67
0.91 (0.62 %)
Ultragenyx Pharmaceutical Inc. Market cap
$9.26 B
WMC RANKING
2021
Ultragenyx Pharmaceutical Inc. # 51
BiotechnologyLatest Ultragenyx Pharmaceutical Inc. News
10 Jan 2021
Short Blade Swim Fins Market Growing Rapidly with Trends ...
6.2 Ultragenyx Pharmaceutical. 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx Pharmaceutical Description, Business Overview and ...
10 Jan 2021
Stevia Sugar Market to Witness Astonishing Growth with Key ...
6 Company Profiles and Key Figures in Stevia Sugar Business. 6.1 Kyowa Kirin ... 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx ...
10 Jan 2021
Industrial Electromagnetic Multi-Disc Clutch Market Growing ...
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3). 2.6 Manufacturers ... 6.2.1 Ultragenyx Pharmaceutical Corporation Information. 6.2.2 Ultragenyx ...
WMC Market Score
WMC Market to Revenue Score
Ultragenyx Pharmaceutical Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Ultragenyx Pharmaceutical Inc. | USD | $121,851 | $562,422 | $-424,996 | $92,600B | 51 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $580,590B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $353,780B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $617,950B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Ultragenyx Pharmaceutical Inc. Social Followers vs Top 4 Industry Competitors
Ultragenyx Pharmaceutical Inc. Post vs Top 4 Industry Competitors
Ultragenyx Pharmaceutical Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Ultragenyx Pharmaceutical Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Ultragenyx Pharmaceutical Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Ultragenyx Pharmaceutical Inc. | 1.32 | 0 | 0 | 0 | 0 | 0 | 0.20 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.47 | 10.77 | 100 | 0 | 0 | 93.77 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.19 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
